The multifaceted activity of VEGF in angiogenesis - Implications for therapy responses

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Vascular endothelial growth factor (VEGF) drives angiogenesis, crucial in both physiological and pathological contexts.
• Anti-VEGF therapies are approved for inhibiting tumor angiogenesis but show limited survival benefits due to acquired resistance.
• Tumor cell adaptability and contributions from stromal cells are key factors in resistance to anti-VEGF treatments.

Purpose of the Study:

• To explore the complex roles of tumor stromal cells in resistance to VEGF blockade.
• To understand the broader impact of VEGF signaling beyond endothelial cells.

Main Methods:

• Review of current literature on VEGF signaling and anti-angiogenic therapy resistance.
• Analysis of studies investigating VEGF receptor expression and function in various stromal cell types.

Main Results:

• VEGF signaling affects not only endothelial cells but also a variety of stromal cells within the tumor microenvironment.
• Stromal cell responses to VEGF blockade contribute significantly to therapeutic resistance.
• The complexity of VEGF signaling in diverse cell types complicates the efficacy of current anti-VEGF strategies.

Conclusions:

• A comprehensive understanding of stromal cell responses to VEGF blockade is essential for overcoming resistance.
• Targeting stromal cell-mediated resistance pathways may lead to more effective anti-angiogenic therapies.
• Future anti-angiogenic drug design should consider the multifaceted roles of VEGF in the tumor ecosystem.